Skip to content
Search

Latest Stories

New repeat prescribing toolkit to improve patient care, reduce medicine waste

New repeat prescribing toolkit to improve patient care, reduce medicine waste

By streamlining repeat prescribing systems, the RPS/RCGP toolkit aims to reduce the impact of overprescribing and problematic polypharmacy

The Royal Pharmaceutical Society (RPS) and the Royal College of GPs (RCGP) have launched a new toolkit to enhance the consistency, safety, and efficiency of repeat prescribing systems in general practices across England.

Commissioned by NHS England, this toolkit is the first national good practice guidance for repeat prescribing in two decades and aims to address issues highlighted by the 2021 National Overprescribing Review.


The review recognised the impact that poorly operated repeat prescribing can have on overprescribing and problematic polypharmacy.

Over 1 billion prescriptions are dispensed annually in England, 77% of which are repeat prescriptions, which account for nearly 80% of NHS primary care medicine costs.

The sheer volume and workload of repeat prescriptions underscore the need for streamlined and improved processes.

The RPS/RCGP Repeat Prescribing Toolkit allows GP practice teams and primary care networks, working in collaboration with community pharmacies and patients, to create a “collaborative, safe and efficient” repeat prescribing process.

This approach aims to enhance patient care by addressing inconsistencies and potential oversupply, whilst reducing unnecessary medicines waste and saving NHS resources.

Clare Howard, RPS Fellow and Clinical Lead author, noted that this toolkit marks a significant step forward in ensuring the safety and efficiency of repeat prescribing systems, ultimately benefiting patients and the NHS as a whole.

“By working together, the RPS and RCGP have developed practical guidance and useful resources which will enable GP practices and Primary Care Networks to self-assess their current arrangements and make meaningful improvements in their repeat prescribing processes,” she explained.

The toolkit also includes practical guidance on improving communication with patients about repeat prescribing, supported by good practice case studies, flow charts, action plan templates, and useful resources.

Dr Michael Mulholland, Honorary Secretary of the RCGP, emphasised that safe and appropriate prescribing is a key skill for GPs, and they take it “very seriously”

“Repeat prescribing makes up a large part of the general practice workload and we need to make sure we are always streamlining and improving the process,” he said.

To complement the toolkit, a new NHS dashboard has been developed to highlight potential oversupply of medicines in various prescribing areas. The dashboard will support improvement initiatives, particularly by identifying inconsistencies in repeat prescribing processes, to help minimise avoidable waste and the risk of patient harm.

Graham Prestwich, patient representative and Board Member at Healthwatch Leeds, stated that the toolkit and associated resources will help make communicating with patients about their repeat medicines “simpler and more effective."

Professor Tony Avery, National Clinical Director for Prescribing at NHS England, emphasised the importance of the tool, stating: “With over one billion prescriptions dispensed annually in England, over three quarters of which are repeat prescriptions, it is essential that repeat prescribing systems in general practices are safe for patients and efficient for all involved.”

The toolkit is now available for use by general practices, Primary Care Networks, Integrated Care Boards, and community pharmacies across England.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less